Analysis of dominant-negative effects of mutant Env proteins of human immunodeficiency virus type 1

Virology

Volumn 286, Issue 1, 2001, Pages 45-53

  Iwatani, Yasumasa ^a   Kawano, Kumi ^b   Ueno, Takaharu ^b   Tanaka, Masakazu ^b   Ishimoto, Akinori ^b   Ito, Masahiko ^a   Sakai, Hiroyuki ^b  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Cytoplasmic tail; HIV 1; Oligomerization; Packaging cell line; TM protein

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; MUTANT PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CELL LINE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; OLIGOMERIZATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; VIRUS INFECTIVITY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0035919637     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.0944     Document Type: Article

References (44)

1. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies
2. Methods for HIV/SIV gene analysis
3. Oligomerization of the hydrophobic heptad repeat of gp41
4. Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site
5. Core structure of gp41 from the HIV envelope glycoprotein
6. Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity
7. Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein
8. Direct interaction between the envelope and matrix proteins of HIV-1
9. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein
10. Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein. Requirement of precursor cleavage for glycoprotein incorporation
11. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity
12. Folding interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein
13. Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomain
14. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity
15. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection
16. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix
17. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions
18. Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160
19. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins
20. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage
21. Modification of virus infectivity by cytoplasmic tail of HIV-1 TM protein
22. HIV requires multiple gp120 molecules for CD4-mediated infection
23. + T lymphocytes
24. The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells
25. A trimeric structural domain of the HIV-1 transmembrane glycoprotein
26. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains
27. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus
28. Mutation-directed chemical cross-linking of human immunodeficiency virus type 1 gp41 oligomers
29. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail
30. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions
31. Characterization of human immunodeficiency virus type 1 matrix revertants: Effects on virus assembly. Gag processing, and Env incorporation into virions
32. Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates
33. Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells
34. Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure
35. Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence
36. Efficient HIV-1 replication can occur in the absence of the viral matrix protein
37. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles
38. Synthesis, assembly, and processing of viral proteins
39. Atomic structure of a thermostable subdomain of HIV-1 gp41
40. Intracellular interaction of simian immunodeficiency virus Gag and Env proteins
41. Atomic structure of the ectodomain from HIV-1 gp41
42. Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins
43. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions
44. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions